These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17138752)

  • 41. Drug discovery in academia.
    Verkman AS
    Am J Physiol Cell Physiol; 2004 Mar; 286(3):C465-74. PubMed ID: 14761879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of industry in bringing foods for particular nutritional uses (PARNUTS) to the market.
    Leathwood P; MacLean W; Uauy R
    Eur J Clin Nutr; 1999 Dec; 53 Suppl 3():S9-13. PubMed ID: 10723641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Academia-industry partnerships in drug discovery.
    Dalrymple M; Taylor D; Kettleborough C; Bryans J; Solari R
    Expert Opin Drug Discov; 2006 Jun; 1(1):1-6. PubMed ID: 23506026
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Developing novel chemical entities for the treatment of lysosomal storage disorders: an academic perspective.
    Shayman JA
    Am J Physiol Renal Physiol; 2015 Dec; 309(12):F996-9. PubMed ID: 26447223
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Industry and the profession of medicine: balancing appropriate relationships with the need for innovation.
    Lewin J; Arend TE
    J Vasc Surg; 2011 Sep; 54(3 Suppl):47S-9S. PubMed ID: 21872116
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The engineers of human souls & academia.
    Healy D
    Epidemiol Psichiatr Soc; 2007; 16(3):205-11. PubMed ID: 18020194
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Collaborations among academia, government, and industry in the diagnostics space: barriers and some ideas for solutions.
    Evans G; Austin F
    Sci Transl Med; 2010 Dec; 2(63):63mr3. PubMed ID: 21178133
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Academia-industry symbiosis in organic chemistry.
    Michaudel Q; Ishihara Y; Baran PS
    Acc Chem Res; 2015 Mar; 48(3):712-21. PubMed ID: 25702529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug Development in Endometriosis and Adenomyosis: It Takes More Than Just Good Science.
    Groothuis PG; Guo SW
    Reprod Sci; 2018 Sep; 25(9):1318-1329. PubMed ID: 29962279
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changing paradigms in animal agriculture: the role of academia and industry in technology transfer.
    Braund DG
    J Anim Sci; 1995 Oct; 73(10):3173-7. PubMed ID: 8617689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Industry-Academic Relationship in a New Era of Drug Discovery.
    Vallance P
    J Clin Oncol; 2016 Oct; 34(29):3570-3575. PubMed ID: 27458309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discovery of PET radiopharmaceuticals at the academia-industry interface.
    Bernard-Gauthier V; Collier TL; Liang SH; Vasdev N
    Drug Discov Today Technol; 2017 Nov; 25():19-26. PubMed ID: 29233263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mentoring the next generation of physician-scientists in Japan: a cross-sectional survey of mentees in six academic medical centers.
    Sakushima K; Mishina H; Fukuhara S; Sada K; Koizumi J; Sugioka T; Kobayashi N; Nishimura M; Mori J; Makino H; Feldman MD
    BMC Med Educ; 2015 Mar; 15():54. PubMed ID: 25890341
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical excellence in academia: perspectives from masterful academic clinicians.
    Christmas C; Kravet SJ; Durso SC; Wright SM
    Mayo Clin Proc; 2008 Sep; 83(9):989-94. PubMed ID: 18775198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Knowledge translation in tri-sectoral collaborations: An exploration of perceptions of academia, industry and healthcare collaborations in innovation adoption.
    Ii SS; Fitzgerald L; Morys-Carter MM; Davie NL; Barker R
    Health Policy; 2018 Feb; 122(2):175-183. PubMed ID: 29191387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Industry Perspective on Biomarker Development and Qualification.
    Gerlach CV; Derzi M; Ramaiah SK; Vaidya VS
    Clin Pharmacol Ther; 2018 Jan; 103(1):27-31. PubMed ID: 29143971
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Regulatory science.
    Uchiyama M
    PDA J Pharm Sci Technol; 1995; 49(4):185-7. PubMed ID: 7552238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of systems approaches on biological problems in drug discovery.
    Hood L; Perlmutter RM
    Nat Biotechnol; 2004 Oct; 22(10):1215-7. PubMed ID: 15470453
    [No Abstract]   [Full Text] [Related]  

  • 59. Is there a best strategy for drug discovery?--SMR Meeting. 13 March 2003, London, UK.
    Lunec A
    IDrugs; 2003 May; 6(5):454-7. PubMed ID: 12841215
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Symposium review: drug discovery, development and clinical research in academia.
    Vlaar CP; Hernández L
    P R Health Sci J; 2009 Sep; 28(3):268-73. PubMed ID: 19715120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.